In vitro and in vivo asessment of adenovirus 41 as a vector for gene delivery to the intestine

Gene Therapy

Volumn 5, Issue 5, 1998, Pages 645-654

  Croyle, M A ^a,b,e   Stone, M ^c   Amidon, G L ^a   Roessler, B J ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus type 41; Adenovirus type 5; Gene delivery; Intestine

Indexed keywords

ADENOVIRUS; ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL STRAIN CACO 2; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTER; GENE TARGETING; INTERNALIZATION; INTESTINE; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; VIRION; VIRUS CELL INTERACTION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL SEPARATION; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GENE VECTOR; GENETICS; HUMAN; INTESTINE MUCOSA; JEJUNUM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; VIROLOGY;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 41; HUMAN ADENOVIRUS TYPE 5;

FLUORESCENT DYE; RHODAMINE; TETRAMETHYLRHODAMINE ISOTHIOCYANATE;

ADENOVIRIDAE; ANIMALS; CACO-2 CELLS; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT DYES; GENETIC VECTORS; HUMANS; INTESTINAL MUCOSA; INTESTINES; JEJUNUM; MICROSCOPY, ELECTRON; RATS; RATS, SPRAGUE-DAWLEY; RHODAMINES; TUMOR CELLS, CULTURED;

EID: 0031593872     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300645     Document Type: Article

References (69)

1. Sandberg JW et al. Improving access to intestinal stem cells as a step toward intestinal gene transfer. Hum Gene Ther 1994; 5: 323-329.
2. Chang AG, Wu GY. Gene therapy: applications to the treatment of gastrointestinal and liver diseases. Gastroenterology 1994; 106: 1076-1084.
3. Colledge WH et al. Cystic fibrosis mouse with intestinal obstruction. Lancet 1992; 340: 680.
4. O'Neal WA et al. A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum Molec Genet 1993; 2: 1561-1569.
5. Westbrook CA et al. Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery. Hum Molec Genet 1994; 3: 2005-2010.
6. Thomas HJ. The genetics and molecular biology of colorectal cancer. Curr Opin Oncol 1991; 3: 702-710.
7. Sweetser DA et al. Transgenic mice containing intestinal fattyacid binding protein-human growth hormone fusion genes exhibit correct regional and cell-specific expression of the reporter gene m their small intestine. Proc Natl Acad Sci USA 1988; 85: 9611-9615.
8. Ledley FD. Somatic gene therapy in gastroenterology: approaches and applications. J Pediatr Gastroenterol Nutr 1992; 14: 328-337.
9. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987; 7: 265-276.
10. Smythe WR et al Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapy. J Thorac Cardiovasc Surg 1995; 109: 626-631.
11. Bellon G et al. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Hum Gene Ther 1997; 8: 15-25
12. Eck SL et al. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Hum Gene Ther 1996; 7: 1465-1482.
13. Tursz T et al. Phase I study of a recombinant adenovirus- mediated gene transfer in lung cancer patients. J Natl Cancer Inst 1996; 88: 1857-1863.
14. Eloit M, Guardi-Hebenstreit P, Toma B, Perricaudet M. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J Gen Virol 1990; 71: 2425-2431.
15. Ragot T et al. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. J Gen Virol 1993; 74: 501-507.
16. Batra RK, Berschneider H, Curiel DT. Molecular conjugate vectors mediate efficient gene transfer into gastrointestinal epithelial cells. Cancer Gene Ther 1994; 3: 185-192.
17. Hamilton TE, DeMatteo RP, Rombeau JL, Raper SE. A comparison of adenoviral and retroviral gene transfer into the small intestine. Surg Forum 1995; 66: 649-650
18. Cheng DY, Kolls JK, Lei D, Noel RA. In vivo and in vitro gene transfer and expression in rat intestinal epithelial cells by E1- deleted adenoviral vector. Hum Gene Ther 1997; 8: 755-764.
19. Brown GR, Thiele DL, Silva M, Beutler B. Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium. Gastroenterology 1997; 112: 1586-1594.
20. Walter E et al. Adenovirus mediated gene transfer to intestinal epithelial cells as a potential approach for oral delivery of peptides and proteins. J Control Rel 1997; 46: 75-87.
21. Rubin BA, Rorke LB. Adenovirus Vaccines. In: Plotkin SA, Mortimer EA (eds). Vaccines. WB Saunders: Philadelphia, 1994, pp 475-502.
22. Tint H, Stone JL, Minecci LC, Rubin BA. Type 4 adenovirus vaccine, live, prepared in human diploid cell system for oral administration. In: Regamey RH, de Barbieri A (eds). Progress in Immunobiological Standards. Karger: Basel, 1969, pp 113-122.
23. Lubeck MD et al. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc Natl Acad Sci USA 1989; 86: 6763-6767.
24. Chengalvala M et al. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Vaccine 1991; 9: 485-490.
25. Tardieu M, Epstein RL, Weiner H. Interaction of viruses with cell surface receptors. Int Rev Cytol 1990; 80: 27-61.
26. Bergelson JM et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
27. Tomko RP, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B Coxsackie viruses. Proc Natl Acad Sci USA 1997; 94: 3352-3356.
28. Philipson L, Lonberg-Holm K, Pettersson U. Virus receptor interaction in an adenovirus system. J Virol 1968; 2: 1064-1075.
29. Fasbender A et al. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 1997; 272: 6479-6489.
30. Fenger TW. Replication of DNA viruses. In: Belshe RB (ed). Textbook of Human Virology. Academic Press: New York, 1984, pp 51-72.
31. de Jong JC et al. Candidate adenoviruses 40 and 41: fastidious adenoviruses from infant stool. J Med Virol 1983; 11: 215-231.
32. Yeh H-Y et al. Human adenovirus type 41 contains two fibers. Virus Res 1994; 33: 179-198.
33. Kidd AH, Chroboczek J, Cusack S, Ruigrok RWH. Adenovirus type 40 virions contain two distinct fibers. Virology 1993; 192: 73-84.
34. Yeh HY, Luftig RB. Human enteric adenovirus type 41 binding to HEp-2 cells is specific. Virology 1991; 183: 410-414.
35. Scott-Taylor TH, Ahluwalia G, Hammond GW. Restriction analysis of the prototype strain of enteric adenovirus type 41 using exonuclease III. J Virol Meth 1992; 38: 25-38.
36. Croyle MA et al. Role of integrin expression in adenovirus- mediated gene delivery to the intestinal epithelium. Hum Gene Ther 1998; 9: 561-573.
37. Walter E, Croyle MA, Roessler BJ, Amidon GL. The absence of accessible vitronectin receptors in differentiated tissue may hinder adenovirus-mediated gene transfer to the intestinal epithelium. Pharm Res 1997; 14: 1216-1222.
38. Russell WC, Kemp GD. Role of adenovirus structural components in the regulation of adenovirus infection. In: Doerfler W, Bohm P (eds). The Molecular Repertoire of Adenoviruses I. Virion Structure and Infection. Springer-Verlag: Berlin, 1995, pp 81-98.
39. Croyle MA et al. Factors that influence stability of recombinant adenoviral preparations for human gene therapy. Pharm Dev Technol (in press).
40. Castro GA. Digestion and absorption. In: Johnson LR (ed) Physiology of the Gastrointestinal Tract. Raven Press: New York, 1985, pp 105-128.
41. Croyle MA, Roessler BJ, Amidon GL. Unique carbohydrate formulations enhance adenoviral-mediated gene delivery to the intestinal epithelium. Pharm Res.
42. Yang Y et al. Cellular immunity to viral antigens limits E1- deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
43. Schulick AH et al. Established immunity precludes adenovirus- mediated gene transfer in rat carotid arteries. J Clin Invest 1997; 99: 209-219.
44. Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung- directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
45. Brandtzaeg P et al. Nature and properties of the human gastrointestinal immune system. In: Miller K, Nicklin S (eds). Immunology of the Gastrointestinal Tract. CRC Press: Boca Raton, 1987, pp 1-27.
46. Wold WSM, Gooding LR. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol Biol Med 1989; 6: 433-452.
47. Lee MG, Abina MA, Haddada H, Perricaudet M. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3-adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector Hum Gene Ther 1995; 2: 256-262.
48. Sparer TE et al. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. J Virol 1997; 71: 2277-2284.
49. Sester M, Burgert HG. Conserved cysteine residues within the E3/19K protein of adenovirus type 2 are essential for binding to major histocompatibility complex antigens. J Virol 1994; 68: 5423-5432.
50. Feuerbach D et al. Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K. J Immunol 1994; 153: 1626-1636.
51. Kolls JK et al. Use of transient cP4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 489-497.
52. Quinones MJ et al. Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication defective adenovirus. Circulation 1996; 94: 1394-1401.
53. Fisher KJ et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996; 217: 11-22.
54. Sparer TE et al. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K and 14.7K) in a murine pneumonia model. J Virol 1996; 70: 2431-2439.
55. Efrat S, Fejer G, Brownlee M, Horwitz MS. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci USA 1995; 92: 6947-6951.
56. Zepeda M, Wilson JM. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors. Gene Therapy 1996; 3: 973-979.
57. Ballard PL et al. Adenovirus-mediated gene transfer to human fetal lung ex vivo. Am J Physiol 1995; 268: L839-L845.
58. Mathias P, Wickham T, Moore M, Nemerow G. Multiple adenovirus serotypes use α, integrins for infection. J Virol 1994; 68: 6811-6814.
59. Graham FL, Smiley J, Russell WC, Nairn R Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74.
60. Moore AE, Sabachewsky L, Toolan HW. Culture characteristics of four permanent lines of human cancer cells. Cancer Res 1955; 15: 598-602.
61. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96: 736-749.
62. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
63. Persson R, Svensson U, Everitt E. Virus receptor interaction in the adenovirus system II. Capping and cooperative binding of virions on HeLa cells. J Virol 1983; 46: 956-963.
64. Nichols JE, Mock DJ, Roberts NJ. Use of FITC-labeled influenza virus and flow cytometry to assess binding and internalization of virus by monocytes-macrophages and lymphocytes. Archiv Virol 1993; 130: 441-455.
65. Chardonnet Y, Dales S. Early events in the interaction of adenoviruses with HeLa cells. III. Relationship between an ATP-ase activity in nuclear envelopes and transfer of core material. Virology 1972; 48: 342-359.
66. Worthington BB, Graney DO. Uptake of adenovirus by intestinal absorptive cells of the suckling rat I. The neonatal ileum. Anat Rec 1973; 175: 37-61.
67. Worthington BB, Graney DO. Uptake of adenovirus by intestinal absorptive cells of the suckling rat II. The neonatal jejunum. Anat Rec 1973; 175: 63-67.
68. Artursson P. Cell cultures as models for drug absorption across the intestinal mucosa. Crit Rev Ther Drug Carrier Sys 1991; 8: 305-330.
69. Miller JH. Experiments in Molecular Genetics. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1972.